The detection and treatment of subclinical atrial fibrillation: evaluating the IMPACT of a comprehensive strategy based on remote arrhythmia monitoring.

Highlights from the Ninth International Symposium of Thrombosis and Anticoagulation (ISTA IX), October 15, 2016, Salvador, Bahia, Brazil. J Thromb Thrombolysis (2017) 0.75

Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices. Eur Heart J (2015) 1.76

The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy). J Am Coll Cardiol (2013) 4.58

Risk factors for mortality in patients admitted to intensive care units with pneumonia. Respir Res (2016) 1.37

Management of patients with implantable cardioverter-defibrillators and pacemakers who require radiation therapy. Heart Rhythm (2015) 0.82

Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trial. Int J Cardiol (2015) 0.77

Erratum to: Risk factors for mortality in patients admitted to intensive care units with pneumonia. Respir Res (2016) 0.75

Heparin bridging in peri-procedural management of new oral anticoagulant: a bridge too far? Eur Heart J (2014) 0.75